Skip to main content

Table 1 Nasal symptom scores and cytokine levels in nasal lavage fluid.

From: Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis

 

Treatment

 
 

Placebo

(n = 11)

Budesonide

(n = 10)

p-value

Symptoms

   

- Morning TNSS

1.0 (1.0)

1.0 (2.0)

0.48

Nasal lavage

   

- CCL5 (pg/ml)

8.5 (9.0)

10.0 (27.6)

0.14

- CCL11 (pg/ml)

8.8 (4.5)

11.0 (13.1)

0.17

  1. Median (IQR) total nasal symptom scores, and lavage fluid levels of CCL5 (RANTES) and CCL11 (eotaxin) on Study day 10 of the second treatment series, i.e., on the day the biopsies were obtained. Data were analysed using the Mann Whitney test (unpaired comparisons). No statistically significant differences were observed between the treatments.
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us